UBS, Shares

UBS Shares Approach Annual Peak Ahead of Earnings Release

01.02.2026 - 03:16:05

UBS CH0244767585

Investor confidence in the European banking sector has propelled UBS Group AG's stock to a notable milestone. On January 27, the Swiss banking giant's shares touched a new 52-week high of $49.36. All eyes are now fixed on the upcoming annual results presentation scheduled for February 4, where Chief Executive Officer Sergio Ermotti will unveil the bank's full-year 2025 performance. Market expectations are elevated following a robust third-quarter report.

The bank enters this crucial reporting period from a position of demonstrated strength. Its third-quarter 2025 figures significantly surpassed analyst forecasts, providing a solid foundation. UBS reported earnings per share of $0.76, starkly outperforming the consensus estimate of $0.48. Revenue also delivered a surprise, reaching $12.76 billion against a projected $9.68 billion.

Key Q3 2025 Financial Highlights:
- Earnings Per Share: $0.76 (Consensus Estimate: $0.48)
- Total Revenue: $12.76 billion (Consensus Estimate: $9.68 billion)
- Year-over-Year Revenue Growth: +4.3%

Further bolstering sentiment, UBS's own equity research team issued positive assessments on European stocks. The bank also acted as a co-underwriter for a refinancing deal exceeding $400 million for Aidacare, demonstrating active capital markets engagement.

Should investors sell immediately? Or is it worth buying UBS?

Proactive Debt Management Initiatives

Parallel to its operational performance, UBS has been actively managing its balance sheet. In January, the institution executed several bond repayments ahead of schedule. A senior notes repayment worth $2 billion, originally due in February 2027, was completed on February 2. This followed another early redemption of $1.3 billion in late January. Additionally, UBS announced the repayment of 60 million Australian dollars in zero-coupon bonds maturing in 2038. These moves are characterized as routine within the bank's ongoing liability management strategy.

Regulatory Hurdles on the Horizon

Not all developments have been favorable. A significant regulatory debate in Switzerland presents a headwind. On January 12, UBS published its response to a Federal Council consultation concerning stricter capital requirements. The bank formally opposes the proposed amendments to the Banking Act and the Capital Adequacy Ordinance, arguing that such changes would impair its international competitiveness.

Forthcoming Financial Calendar

The presentation of the annual results will be broadcast via webcast on February 4, commencing at 09:00 Central European Time. Supporting documentation will be accessible from 06:45 CET on the bank's dedicated quarterly reporting website at ubs.com/quarterlyreporting. Subsequent key dates include the publication of the full Annual Report on March 9 and the Annual General Meeting scheduled for April 15, 2026.

Ad

UBS Stock: Buy or Sell?! New UBS Analysis from February 1 delivers the answer:

The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 1.

UBS: Buy or sell? Read more here...

@ boerse-global.de | CH0244767585 UBS